XML 27 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-Based Compensation
3 Months Ended
Mar. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
STOCK-BASED COMPENSATION
STOCK-BASED COMPENSATION
We recorded and allocated employee stock-based compensation expense for our equity incentive plans and our 2000 Employee Stock Purchase Plan (“ESPP”) as follows (in thousands):
 
Three Months Ended March 31,
 
2018
 
2017
Research and development
$
3,033

 
$
1,478

Selling, general and administrative
6,272

 
3,235

Total stock-based compensation
$
9,305

 
$
4,713


We have several equity incentive plans under which we have granted stock options and restricted stock units (“RSUs”) to employees, directors and consultants. At March 31, 2018, 19,972,317 shares were available for grant under our equity incentive plans.
We use the Black-Scholes Merton option pricing model to value our stock options and ESPP purchases. The weighted average grant-date fair value per share of our stock options and ESPP purchases was as follows:
 
Three Months Ended March 31,
 
2018
 
2017
Stock options
$
11.52

 
$
9.92

ESPP
$
7.39

 
$
3.71


The grant-date fair value of employee stock option grants and ESPP purchases was estimated using the following assumptions:
 
Three Months Ended March 31,
 
2018
 
2017
Stock options:
 
 
 
Risk-free interest rate
2.40
%
 
1.62
%
Dividend yield
%
 
%
Volatility
54
%
 
64
%
Expected life
4.0 years

 
4.0 years

ESPP:
 
 
 
Risk-free interest rate
1.53
%
 
0.62
%
Dividend yield
%
 
%
Volatility
53
%
 
68
%
Expected life
6 months

 
6 months


We considered our implied volatility and our historical volatility in developing our estimates of expected volatility. The assumptions for the expected life of stock options were based on historical exercise patterns and post-vesting termination behavior.
The fair value of RSUs was based on the closing price of the underlying common stock on the date of grant.
Stock option activity for the three months ended March 31, 2018 was as follows (dollars in thousands, except per share amounts):
 
Shares
 
Weighted
Average
Exercise Price Per Share
 
Weighted
Average
Remaining Contractual
Term
 
Aggregate
Intrinsic
Value
Options outstanding at December 31, 2017
22,208,446

 
$
6.83

 
 
 
 
Granted
293,580

 
$
25.72

 
 
 
 
Exercised
(288,196
)
 
$
6.69

 
 
 
 
Forfeited
(18,484
)
 
$
12.04

 
 
 
 
Options outstanding at March 31, 2018
22,195,346

 
$
7.08

 
3.86 years
 
$
339,631

Exercisable at March 31, 2018
16,497,014

 
$
4.66

 
3.30 years
 
$
288,535


As of March 31, 2018, $38.8 million of unrecognized compensation expense related to unvested stock options will be recognized over a weighted-average period of 2.47 years.
RSU activity for the three months ended March 31, 2018 was as follows (dollars in thousands, except per share amounts):
 
Shares
 
Weighted
Average
Grant Date
Fair Value Per Share
 
Weighted
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
RSUs outstanding at December 31, 2017
3,762,990

 
$
17.76

 
 
 
 
Awarded
146,790

 
$
25.72

 
 
 
 
Vested and released
(197,884
)
 
$
6.30

 
 
 
 
Forfeited
(24,494
)
 
$
17.89

 
 
 
 
RSUs outstanding at March 31, 2018
3,687,402

 
$
18.69

 
1.83 years
 
$
81,676


As of March 31, 2018, $60.0 million of unrecognized compensation expense related to unvested RSUs will be recognized over a weighted-average period of 3.05 years.